Sarcoidosis following alemtuzumab treatment for multiple sclerosis. (2018)

First Author: Willis MD
Attributed to:  MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/1352458518790391

PubMed Identifier: 30307364

Publication URI: http://europepmc.org/abstract/MED/30307364

Type: Journal Article/Review

Volume: 24

Parent Publication: Multiple sclerosis (Houndmills, Basingstoke, England)

Issue: 13

ISSN: 1352-4585